Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer
J Clin Oncol
.
2024 Apr 9:JCO2302614.
doi: 10.1200/JCO.23.02614.
Online ahead of print.
Authors
Alejandro Ríos-Hoyo
1
,
Erin Cobain
2
,
Laura A Huppert
3
,
Peter D Beitsch
4
,
Thomas A Buchholz
5
,
Laura Esserman
3
,
Laura J van 't Veer
3
,
Hope S Rugo
3
,
Lajos Pusztai
1
Affiliations
1
Yale Cancer Center, Yale School of Medicine, New Haven, CT.
2
University of Michigan, Ann Arbor, MI.
3
University of California San Francisco Comprehensive Cancer Center, San Francisco, CA.
4
Dallas Surgical Group, Dallas, TX.
5
Scripps Health, Scripps Clinic Medical Group, San Diego, CA.
PMID:
38593393
DOI:
10.1200/JCO.23.02614
No abstract available